These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11558570)

  • 21. The enantiomer of progesterone (ent-progesterone) is a competitive inhibitor of human cytochromes P450c17 and P450c21.
    Auchus RJ; Sampath Kumar A; Andrew Boswell C; Gupta MK; Bruce K; Rath NP; Covey DF
    Arch Biochem Biophys; 2003 Jan; 409(1):134-44. PubMed ID: 12464252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).
    Wen X; Wang JS; Kivistö KT; Neuvonen PJ; Backman JT
    Br J Clin Pharmacol; 2001 Nov; 52(5):547-53. PubMed ID: 11736863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate.
    Kobayashi K; Mimura N; Fujii H; Minami H; Sasaki Y; Shimada N; Chiba K
    Clin Cancer Res; 2000 Aug; 6(8):3297-303. PubMed ID: 10955816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of human and rat testicular steroidogenic enzyme activities by bisphenol A.
    Ye L; Zhao B; Hu G; Chu Y; Ge RS
    Toxicol Lett; 2011 Nov; 207(2):137-42. PubMed ID: 21925253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethanol oxidation into acetaldehyde by 16 recombinant human cytochrome P450 isoforms: role of CYP2C isoforms in human liver microsomes.
    Hamitouche S; Poupon J; Dreano Y; Amet Y; Lucas D
    Toxicol Lett; 2006 Dec; 167(3):221-30. PubMed ID: 17084997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the activity of human 17 alpha-hydroxylase-17,20-lyase (CYP17) by cytochrome b5: endocrinological and mechanistic implications.
    Lee-Robichaud P; Wright JN; Akhtar ME; Akhtar M
    Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):901-8. PubMed ID: 8948449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of bisphenol A on drug metabolising enzymes in rat hepatic microsomes and precision-cut rat liver slices.
    Pfeiffer E; Metzler M
    Arch Toxicol; 2004 Jul; 78(7):369-77. PubMed ID: 15114436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.
    Murayama N; Imai N; Nakane T; Shimizu M; Yamazaki H
    Biochem Pharmacol; 2007 Jun; 73(12):2020-6. PubMed ID: 17433262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SPR-Based study of affinity of cytochrome P450s / redox partners interactions modulated by steroidal substrates.
    Ershov PV; Yablokov ЕO; Florinskaya AV; Mezentsev YV; Kaluzhskiy LА; Tumilovich AM; Gilep АА; Usanov SA; Ivanov АS
    J Steroid Biochem Mol Biol; 2019 Mar; 187():124-129. PubMed ID: 30468857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor.
    Tang C; Shou M; Mei Q; Rushmore TH; Rodrigues AD
    J Pharmacol Exp Ther; 2000 May; 293(2):453-9. PubMed ID: 10773015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells.
    Wu Y; Chitranshi P; Loukotková L; Gamboa da Costa G; Beland FA; Zhang J; Fang JL
    Arch Toxicol; 2017 Jun; 91(6):2405-2423. PubMed ID: 27896399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bisphenol A and its biomaterial monomer derivatives alteration of in vitro cytochrome P450 metabolism in rat, minipig, and human.
    Cannon JM; Kostoryz E; Russo KA; Smith RE; Yourtee DM
    Biomacromolecules; 2000; 1(4):656-64. PubMed ID: 11710196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes.
    Miyazawa M; Shindo M; Shimada T
    Drug Metab Dispos; 2002 May; 30(5):602-7. PubMed ID: 11950794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine.
    Ring BJ; Eckstein JA; Gillespie JS; Binkley SN; VandenBranden M; Wrighton SA
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1044-50. PubMed ID: 11356927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
    Li XQ; Andersson TB; Ahlström M; Weidolf L
    Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of human steroidogenic cytochrome P450 c17 by 21-hydroxypregnenolone and related steroid hormones.
    Niwa T; Imamura H; Katagiri M
    Biol Pharm Bull; 2012; 35(9):1594-7. PubMed ID: 22975514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovine steroid 17alpha-hydroxylase cytochrome P450: characteristics of the hydroxylase and lyase activities of the adrenal cortex enzyme.
    Swart P; Lombard N; Swart AC; van der Merwe T; Murry BA; Nicol M; Ian Mason J
    Arch Biochem Biophys; 2003 Jan; 409(1):145-52. PubMed ID: 12464253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [O-methyl 14C]naproxen O-demethylase activity in human liver microsomes: evidence for the involvement of cytochrome P4501A2 and P4502C9/10.
    Rodrigues AD; Kukulka MJ; Roberts EM; Ouellet D; Rodgers TR
    Drug Metab Dispos; 1996 Jan; 24(1):126-36. PubMed ID: 8825200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYP2C8/9 mediate dapsone N-hydroxylation at clinical concentrations of dapsone.
    Winter HR; Wang Y; Unadkat JD
    Drug Metab Dispos; 2000 Aug; 28(8):865-8. PubMed ID: 10901692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
    Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
    Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.